Erratum to “Fibromyalgia Syndrome: Etiology, Pathogenesis, Diagnosis, and Treatment”
Author(s) -
Enrico Bellato,
Eleonora Marini,
Filippo Castoldi,
Nicola Barbasetti,
Lorenzo Mattei,
Davide Edoardo Bonasia,
Davide Blonna
Publication year - 2013
Publication title -
pain research and treatment
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 29
eISSN - 2090-1550
pISSN - 2090-1542
DOI - 10.1155/2013/960270
Subject(s) - medicine , etiology , fibromyalgia , fibromyalgia syndrome , pathogenesis , dermatology , intensive care medicine , bioinformatics , physical therapy , pathology , biology
In this paper which appeared in Pain Research and Treatment (Volume 2012, Article ID 426130) the affiliations have been switched. The affiliations should appear as shown above. Moreover in Table 3 on page 10 the NNTs of Milnacipran and of Duloxetine have been switched. The NNTs should appear as follows: Milnacipran NNT 19 (95% CI 7.4, 20.5) and Duloxetine NNT 7.2 (95% CI 5.2, 11.4). The corrected full Table 3 is shown later. Table 3 Comparison between American Pain Society (APS) and Association of the Scientific Medical Societies in Germany (AWMF) with European League Against Rheumatism (EULAR).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom